Recombinant Human Erythropoietin and Peritoneal Dialysis

Zappacosta AR , Caro J , Erslev AJ . Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. Am J Med 1982; 72: 53–7.

McGonigle RJS , Husserl F , Wallin JD , Fisher JW . Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure. Kidney Int 1984; 25: 430–6.

Wideroe TE , Sanengen T , Halvorsen S. Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis. Kidney Int 1983; 24 (suppl. 16): S208–S217.

Lamperi S , Carozzi S , Icardi A. In vitro and in vivo studies of erythropoiesis during CAPD. Perit Dial Bull 1983;3:94–6.

Oreopoulos DG , Robson M , Faller B , Continuous ambulatory peritoneal dialysis. A new era in the treatment of chronic renal failure. Clin Nephrol 1979; 11:125–8.

Panarello G , Pierratos A , Khanna R , Digenis GE . Small doses of deca-durabolin decrease transfusion requirements in anemic CAPD patients. Perit Dial Bull 1982; 2: 143.

Lameire N , Matthys E , De Paepe M , Sys E , Schelstraete , Ringoir S. Red-cell survival in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 1986; 6: 65–8.

Jacobs K , Shoemaker C , Rubersdorf R , Isolation and characterization of genonic and cDNA clones of human erythropoietin. Nature 1985; 313: 806–9.

Winearls CG , Oliver DO , Pippard MJ , Reid C , Downing MR , Cotes PM . Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2: 1175–8.

Eschbach JW , Egrie JC , Downing MR , Browne JK , Adamson JW . Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. New Engl J Med 1987;316:73–8.

Casati S , Passerini P , Campise MR , Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J 1987; 295: 1017–20.

Eschbach JW , Adamson JW . Correction of anemia of hemodialysis (HD) patients with recombinant human erythropoietin (r-Hu EPO). Results of a multicentre study (Abstract). Kidney Int 1988; 33: 189.

Bargman JM , Breborowicz A , Rodela H , Abraham G , Oreopoulos DG . Absorption of recombinant human erythropoietin (EPO) from the peritoneal cavity in rabbits (Abstract). Kidney Int 1988; 33: 243.

Macdougal IC , Roberts DE , Neubert P , Dharmasena AD , Coles GA , Williams JD . Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet 1989; 1:425–7.

Boelaert JR , Schurgers ML , Matthys EG , Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1989; 9: 95–8.

Egrie JC , Eschbach JW , McGuire T , Adamson JW . Pharmacokinetics of recombinant human erythropoietin (r-Hu EPO) administered to hemodialysis (HD) patients. (Abstract). Kidney Int, 1988; 33: 262.

Wikstrom B , Salmonson T , Grahnen A , Danielson BG . Pharmacokinetics of recombinant human erythropoietin in hemodialysis patients (Abstract). Nephrol Dial Transplant 1988; 3: 503.

Sinai-Trieman L , Salusky IB , Fine RN . Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis. J Pediatr 1989; 114: 550–4.

Boelaert JR , Schurgers ML , Matthys EG , Daneeis RF . Routes of administration of r-Hu EPO in CAPD. Nephrol Dial Transplant 1989; 4: 676.

Bommer J , Ritz E , Weinreich T , Bommer G , Ziegler T. Subcutaneous erythropoietin. Lancet 1988; 2: 406.